Emergency Use Authorization
The FDA may authorize unapproved medical products or unapproved uses of approved medical products for emergency use.
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.
The FDA is committed to promoting patient access to safe and effective medical products and ensuring a secure food supply.
Learn MoreOutbreak response, medical countermeasures, supply chain shortages, and preparedness for threats - chemical, biological, radiological, and nuclear (CBRN)
See ResourcesFDA's role in coordinating emergency and crisis response activities involving FDA-regulated products.
FDA Emergency ResponseThe FDA may authorize unapproved medical products or unapproved uses of approved medical products for emergency use.
The FDA coordinates and regulates expiration date extension when needed during public health emergencies and other crises.
FDA coordinates medical countermeasure (MCM) development, preparedness, and response.